Noel FrenchUnderstandable that a lot of my fellow diabetics are worried about Ozempic supply, but blaming people who are using it off label or using WeGovy as intended for weight loss is misplaced. Weight loss is a valid medical use; being overweight can contribute or lead to health issues (including diabetes!). Even purely from an aesthetic standpoint, we obviously live in a society that treats overweight people poorly - I say this from experience as someone who has been quite fit and quite fat. 1/2
I find it hard to blame anyone who uses a tool to reduce the thing that causes people to experience stigma such that life is often simply worse (and of course it shouldn't be that way, but it is!).
Anyway, the appropriate party to blame here, if anyone, is Novo Nordisk for failing to adequately increase supply, not people using a medication.
An off my chest brought to you by something I read on another site where I can't respond without blowing up relationships. 2/2